Loading...
XJPX
4578
Market cap24bUSD
Jul 29, Last price  
7,122.00JPY
1D
1.60%
1Q
2.37%
Jan 2017
39.84%
IPO
256.28%
Name

Otsuka Holdings Co Ltd

Chart & Performance

D1W1MN
P/E
10.80
P/S
1.59
EPS
659.16
Div Yield, %
1.68%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
10.78%
Revenues
2.33t
+15.42%
955,947,000,0001,084,291,000,0001,090,212,000,0001,154,573,000,0001,218,055,000,0001,452,759,000,0001,599,424,000,0001,445,227,000,0001,195,547,000,0001,239,952,000,0001,291,981,000,0001,396,240,000,0001,422,826,000,0001,498,276,000,0001,737,998,000,0002,018,568,000,0002,329,861,000,000
Net income
343.12b
+182.13%
47,083,000,00067,443,000,00081,001,000,00092,174,000,000122,429,000,000150,989,000,000151,237,000,00084,086,000,00092,563,000,000112,492,000,00082,492,000,000127,151,000,000148,137,000,000125,463,000,000133,906,000,000121,616,000,000343,120,000,000
CFO
354.64b
+25.21%
58,470,000,000173,508,000,00086,393,000,000147,618,000,000119,340,000,000226,461,000,000118,046,637,155253,873,000,000142,004,000,000102,832,000,000135,821,000,000192,634,000,000232,839,000,000228,864,000,000211,848,000,000283,232,000,000354,638,000,000
Dividend
Jun 27, 20250 JPY/sh
Earnings
Jul 29, 2025

Profile

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
URL
https://www.otsuka.com/jp/
IPO date
Dec 15, 2010
Employees
33,482
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,329,861,000
15.42%
2,018,568,000
16.14%
1,737,998,000
16.00%
Cost of revenue
1,933,010,000
1,726,378,000
1,568,860,000
Unusual Expense (Income)
NOPBT
396,851,000
292,190,000
169,138,000
NOPBT Margin
17.03%
14.48%
9.73%
Operating Taxes
(11,417,000)
17,155,000
35,534,000
Tax Rate
5.87%
21.01%
NOPAT
408,268,000
275,035,000
133,604,000
Net income
343,120,000
182.13%
121,616,000
-9.18%
133,906,000
6.73%
Dividends
(66,763,000)
(55,653,000)
(55,561,000)
Dividend yield
1.43%
1.94%
2.38%
Proceeds from repurchase of equity
(50,016,000)
(1,000)
BB yield
1.07%
0.00%
Debt
Debt current
28,496,000
88,272,000
44,157,000
Long-term debt
255,645,000
201,477,000
223,950,000
Deferred revenue
44,869,000
50,736,000
Other long-term liabilities
167,536,000
59,740,000
70,826,000
Net debt
(456,812,000)
(700,041,000)
(622,691,000)
Cash flow
Cash from operating activities
354,638,000
283,232,000
211,848,000
CAPEX
(95,558,000)
(114,673,000)
(107,787,000)
Cash from investing activities
(265,793,000)
(190,538,000)
(81,575,000)
Cash from financing activities
(189,367,000)
(60,168,000)
(95,474,000)
FCF
256,635,000
150,796,000
102,834,000
Balance
Cash
426,173,000
513,341,000
489,115,000
Long term investments
314,780,000
476,449,000
401,683,000
Excess cash
624,459,950
888,861,600
803,898,100
Stockholders' equity
2,030,678,000
1,974,755,000
1,800,822,000
Invested Capital
2,510,623,050
1,866,251,400
1,746,031,900
ROIC
18.66%
15.23%
7.92%
ROCE
12.66%
10.50%
6.56%
EV
Common stock shares outstanding
541,404
542,668
542,556
Price
8,600.00
62.60%
5,289.00
22.86%
4,305.00
3.26%
Market cap
4,656,071,691
62.22%
2,870,171,052
22.88%
2,335,703,580
3.30%
EV
4,243,843,691
2,212,764,052
1,750,152,580
EBITDA
504,827,000
389,967,000
262,899,000
EV/EBITDA
8.41
5.67
6.66
Interest
8,791,000
6,523,000
6,063,000
Interest/NOPBT
2.22%
2.23%
3.58%